The role of the immune response in age-related macular degeneration

International Journal of Inflammation

Volumn 2013, Issue , 2013, Pages

  Whitcup, Scott M ^a   Sodhi, Akrit ^b   Atkinson, John P ^c   Holers, V Michael ^d   Sinha, Debasish ^b   Rohrer, Bärbel ^e   Dick, Andrew D ^f,g  

^a ALLERGAN INC   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CRYOPYRIN; CYTOKINE; INFLAMMASOME;

ADAPTIVE IMMUNITY; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; T LYMPHOCYTE;

EID: 84878684237     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2013/348092     Document Type: Review

References (89)

1. Friedman D. S., O'Colmain B. J., Muñoz B., Tomany S. C., McCarty C., DeJong P. T. V. M., Nemesure B., Mitchell P., Kempen J., Congdon N., Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004 122 4 564 572 2-s2.0-11144354339 10.1001/archopht.122.4.564 (Pubitemid 38456293)
2. Lim L. S., Mitchell P., Seddon J. M., Holz F. G., Wong T. Y., Age-related macular degeneration. The Lancet 2012 379 9827 1728 1738 10.1016/S0140-6736(12) 60282-7
3. Penfold P. L., Madigan M. C., Gillies M. C., Provis J. M., Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research 2001 20 3 385 414 2-s2.0-0035077783 10.1016/S1350-9462(00)00025-2 (Pubitemid 32245687)
4. Carter D. A., Dick A. D., CD200 maintains microglial potential to migrate in adult human retinal explant model. Current Eye Research 2004 28 6 427 436 2-s2.0-4143088416 10.1080/02713680490503778 (Pubitemid 39090327)
5. Broderick C., Hoek R. M., Forrester J. V., Liversidge J., Sedgwick J. D., Dick A. D., Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. The American Journal of Pathology 2002 161 5 1669 1677 2-s2.0-0036841128 (Pubitemid 35265526)
6. Saijo K., Glass C. K., Microglial cell origin and phenotypes in health and disease. Nature Reviews Immunology 2011 11 11 775 787 10.1038/nri3086
7. Broderick C., Duncan L., Taylor N., Dick A. D., IFN- γ and LPS-mediated IL-10-dependent suppression of retinal microglial activation. Investigative Ophthalmology and Visual Science 2000 41 9 2613 2622 2-s2.0-0033863363 (Pubitemid 30624390)
8. Hughes E. H., Schlichtenbrede F. C., Murphy C. C., Broderick C., Van Rooijen N., Ali R. R., Dick A. D., Minocycline delays photoreceptor death in the rds mouse through a microglia-independent mechanism. Experimental Eye Research 2004 78 6 1077 1084 2-s2.0-1942454795 10.1016/j.exer.2004.02.002 (Pubitemid 38510345)
9. Dick A. D., Carter D., Robertson M., Broderick C., Hughes E., Forrester J. V., Liversidge J., Control of myeloid activity during retinal inflammation. Journal of Leukocyte Biology 2003 74 2 161 166 2-s2.0-0041850026 10.1189/jlb.1102535 (Pubitemid 38040411)
10. Medzhitov R., Origin and physiological roles of inflammation. Nature 2008 454 7203 428 435 2-s2.0-47949099098 10.1038/nature07201
11. Xu H., Chen M., Forrester J. V., Para-inflammation in the aging retina. Progress in Retinal and Eye Research 2009 28 5 348 368 2-s2.0-67651155742 10.1016/j.preteyeres.2009.06.001
12. Raychaudhuri S., Iartchouk O., Chin K., Tan P. L., Tai A. K., Ripke S., Gowrisankar S., Vemuri S., Montgomery K., Yu Y., Reynolds R., Zack D. J., Campochiaro B., Campochiaro P., Katsanis N., Daly M. J., Seddon J. M., A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nature Genetics 2011 43 12 1232 1236 10.1038/ng.976
13. Richards A., Kavanagh D., Atkinson J. P., Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration. Advances in Immunology 2007 96 141 177 2-s2.0-35548956373 10.1016/S0065-2776(07)96004-6 (Pubitemid 350018719)
14. Goodship T. H. J., Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD. Kidney International 2006 70 1 12 13 2-s2.0-33745711921 10.1038/sj.ki.5001612 (Pubitemid 44000114)
15. Lachmann P. J., Smith R. A. G., Taking complement to the clinic-has the time finally come? Scandinavian Journal of Immunology 2009 69 6 471 478 2-s2.0-65349094547 10.1111/j.1365-3083.2009.02258.x
16. Tuo J., Grob S., Zhang K., Chan C. C., Genetics of immunological and inflammatory components in age-related macular degeneration. Ocular Immunology and Inflammation 2012 20 1 27 36 10.3109/09273948.2011.628432
17. Sparrow J. R., Ueda K., Zhou J., Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. Molecular Aspects of Medicine 2012 33 4 436 445 10.1016/j.mam.2012.03.007
18. Zipfel P. F., Lauer N., Skerka C., The role of complement in AMD. Advances in Experimental Medicine and Biology 2010 703 9 24 2-s2.0-79952116779 10.1007/978-1-4419-5635-4-2
19. Gehrs K. M., Jackson J. R., Brown E. N., Allikmets R., Hageman G. S., Complement, age-related macular degeneration and a vision of the future. Archives of Ophthalmology 2010 128 3 349 358 2-s2.0-77749307396 10.1001/archophthalmol.2010.18
20. Anderson D. H., Radeke M. J., Gallo N. B., Chapin E. A., Johnson P. T., Curletti C. R., Hancox L. S., Hu J., Ebright J. N., Malek G., Hauser M. A., Bowes Rickman C., Bok D., Hageman G. S., Johnson L. V., The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Progress in Retinal and Eye Research 2010 29 2 95 112 2-s2.0-77249147331 10.1016/j.preteyeres.2009.11.003
21. Khandhadia S., Cipriani V., Yates J. R., Lotery A. J., Age-related macular degeneration and the complement system. Immunobiology 2012 217 2 127 146 10.1016/j.imbio.2011.07.019
22. Bhutto I., Lutty G., Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Molecular Aspects of Medicine 2012 33 4 295 317 10.1016/j.mam.2012.04.005
23. Despriet D. D. G., Klaver C. C. W., Witteman J. C. M., Bergen A. A. B., Kardys I., De Maat M. P. M., Boekhoorn S. S., Vingerling J. R., Hofman A., Oostra B. A., Uitterlinden A. G., Stijnen T., Van Duijn C. M., De Jong P. T. V. M., Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Journal of the American Medical Association 2006 296 3 301 309 2-s2.0-33746041795 10.1001/jama.296.3.301 (Pubitemid 44079314)
24. Fett A. L., Hermann M. M., Muether P. S., Kirchhof B., Fauser S., Immunohistochemical localization of complement regulatory proteins in the human retina. Histol Histopathol 2012 27 3 357 364
25. Sofat R., Casas J. P., Webster A. R., Bird A. C., Mann S. S., Yates J. R., Moore A. T., Sepp T., Cipriani V., Bunce C., Khan J. C., Shahid H., Swaroop A., Abecasis G., Branham K. E., Zareparsi S., Bergen A. A., Klaver C. C., Baas D. C., Zhang K., Chen Y., Gibbs D., Weber B. H., Keilhauer C. N., Fritsche L. G., Lotery A., Cree A. J., Griffiths H. L., Bhattacharya S. S., Chen L. L., Jenkins S. A., Peto T., Lathrop M., Leveillard T., Gorin M. B., Weeks D. E., Ortube M. C., Ferrell R. E., Jakobsdottir J., Conley Y. P., Rahu M., Seland J. H., Soubrane G., Topouzis F., Vioque J., Tomazzoli L., Young I., Whittaker J., Chakravarthy U., de Jong P. T., Smeeth L., Fletcher A., Hingorani A. D., Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. International Journal of Epidemiology 2012 41 1 250 262 10.1093/ije/dyr204
26. Haines J. L., Hauser M. A., Schmidt S., Scott W. K., Olson L. M., Gallins P., Spencer K. L., Shu Y. K., Noureddine M., Gilbert J. R., Schnetz-Boutaud N., Agarwal A., Postel E. A., Pericak-Vance M. A., Complement factor H variant increases the risk of age-related macular degeneration. Science 2005 308 5720 419 421 2-s2.0-20244388812 10.1126/science.1110359 (Pubitemid 40530081)
27. Edwards A. O., Ritter R., Abel K. J., Manning A., Panhuysen C., Farrer L. A., Complement factor H polymorphism and age-related macular degeneration. Science 2005 308 5720 421 424 2-s2.0-17244379811 10.1126/science.1110189 (Pubitemid 40530082)
28. Klein R. J., Zeiss C., Chew E. Y., Tsai J. Y., Sackler R. S., Haynes C., Henning A. K., SanGiovanni J. P., Mane S. M., Mayne S. T., Bracken M. B., Ferris F. L., Ott J., Barnstable C., Hoh J., Complement factor H polymorphism in age-related macular degeneration. Science 2005 308 5720 385 389 2-s2.0-20244380171 10.1126/science.1109557 (Pubitemid 40530070)
29. Hageman G. S., Anderson D. H., Johnson L. V., Hancox L. S., Taiber A. J., Hardisty L. I., Hageman J. L., Stockman H. A., Borchardt J. D., Gehrs K. M., Smith R. J. H., Silvestri G., Russell S. R., Klaver C. C. W., Barbazetto I., Chang S., Yannuzzi L. A., Barile G. R., Merriam J. C., Smith R. T., Olsh A. K., Bergeron J., Zernant J., Merriam J. E., Gold B., Dean M., Allikmets R., A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7227 7232 2-s2.0-21044453724 10.1073/pnas.0501536102 (Pubitemid 40696361)
30. Montes T., Tortajada A., Morgan B. P., De Córdoba S. R., Harris C. L., Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proceedings of the National Academy of Sciences of the United States of America 2009 106 11 4366 4371 2-s2.0-63449141168 10.1073/pnas.0812584106
31. Sjöberg A. P., Trouw L. A., Clark S. J., Sjölander J., Heinegård D., Sim R. B., Day A. J., Blom A. M., The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. Journal of Biological Chemistry 2007 282 15 10894 10900 2-s2.0-34249740145 10.1074/jbc.M610256200 (Pubitemid 47100772)
32. Ormsby R. J., Ranganathan S., Tong J. C., Griggs K. M., Dimasi D. P., Hewitt A. W., Burdon K. P., Craig J. E., Hoh J., Gordon D. L., Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Investigative Ophthalmology and Visual Science 2008 49 5 1763 1770 2-s2.0-44649138189 10.1167/iovs.07-1297
33. Clark S. J., Perveen R., Hakobyan S., Morgan B. P., Sim R. B., Bishop P. N., Day A. J., Impaired binding of the age-related macular degeneration- associated complement factor H 402H allotype to Bruch's membrane in human retina. The Journal of Biological Chemistry 2010 285 39 30192 30202 2-s2.0-77956897697 10.1074/jbc.M110.103986
34. Laine M., Jarva H., Seitsonen S., Haapasalo K., Lehtinen M. J., Lindeman N., Andersen D. H., Johnson P. T., Järvelä I., Jokiranta T. S., Hageman G. S., Inanionen I., Meri S., Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. The Journal of Immunology 2007 178 6 3831 3836 2-s2.0-33947214392 (Pubitemid 46417652)
35. Hageman G. S., Luthert P. J., Victor Chong N. H., Johnson L. V., Anderson D. H., Mullins R. F., An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 2001 20 6 705 732 2-s2.0-0034832029 10.1016/S1350-9462(01)00010-6 (Pubitemid 32918285)
36. Anderson D. H., Mullins R. F., Hageman G. S., Johnson L. V., A role for local inflammation in the formation of drusen in the aging eye. American Journal of Ophthalmology 2002 134 3 411 431 2-s2.0-0036741098 10.1016/S0002-9394(02) 01624-0
37. Mullins R. F., Aptsiauri N., Hageman G. S., Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 2001 15 3 390 395 2-s2.0-0034954060 (Pubitemid 32600863)
38. Johnson L. V., Leitner W. P., Staples M. K., Anderson D. H., Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Experimental Eye Research 2001 73 6 887 896 2-s2.0-0035699547 10.1006/exer.2001.1094 (Pubitemid 34112114)
39. Horstmann R. D., Sievertsen H. J., Knobloch J., Fischetti V. A., Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proceedings of the National Academy of Sciences of the United States of America 1988 85 5 1657 1661 2-s2.0-0343017792 (Pubitemid 18070814)
40. Lambris J. D., Ricklin D., Geisbrecht B. V., Complement evasion by human pathogens. Nature Reviews Microbiology 2008 6 2 132 142 2-s2.0-38349048514 10.1038/nrmicro1824
41. Lauer N., Mihlan M., Hartmann A., Schlotzer-Schrehardt U., Keilhauer C., Scholl H. P., Charbel Issa P., Holz F., Weber B. H., Skerka C., Zipfel P. F., Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant. The Journal of Immunology 2011 187 8 4374 4383 10.4049/jimmunol.1002488
42. Clark S. J., Higman V. A., Mulloy B., Perkins S. J., Lea S. M., Sim R. B., Day A. J., His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. The Journal of Biological Chemistry 2006 281 34 24713 24720 2-s2.0-33747700932 10.1074/jbc.M605083200 (Pubitemid 44274245)
43. Hollyfield J. G., Bonilha V. L., Rayborn M. E., Yang X., Shadrach K. G., Lu L., Ufret R. L., Salomon R. G., Perez V. L., Oxidative damage-induced inflammation initiates age-related macular degeneration. Nature Medicine 2008 14 2 194 198 2-s2.0-38949185692 10.1038/nm1709 (Pubitemid 351214555)
44. Johnson P. T., Betts K. E., Radeke M. J., Hageman G. S., Anderson D. H., Johnson L. V., Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17456 17461 2-s2.0-33751243644 10.1073/pnas.0606234103 (Pubitemid 44788990)
45. Lachmann P. J., The amplification loop of the complement pathways. Advances in Immunology 2009 104 115 149 2-s2.0-77953266787
46. Seddon J. M., Reynolds R., Maller J., Fagerness J. A., Daly M. J., Rosner B., Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Investigative Ophthalmology and Visual Science 2009 50 5 2044 2053 2-s2.0-65549129157 10.1167/iovs.08-3064
47. Reynolds R., Hartnett M. E., Atkinson J. P., Giclas P. C., Rosner B., Seddon J. M., Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Investigative Ophthalmology and Visual Science 2009 50 12 5818 5827 2-s2.0-73349112242 10.1167/iovs.09-3928
48. Scholl H. P. N., Issa P. C., Walier M., Janzer S., Pollok-Kopp B., Börncke F., Fritsche L. G., Chong N. V., Fimmers R., Wienker T., Holz F. G., Weber B. H. F., Oppermann M., Systemic complement activation in age-related macular degeneration. PLoS ONE 2008 3 7 2-s2.0-49749150467 10.1371/journal.pone. 0002593 e2593
49. Wang J., Ohno-Matsui K., Yoshida T., Shimada N., Ichinose S., Sato T., Mochizuki M., Morita I., Amyloid- β up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: another mechanism of complement activation in age-related macular degeneration. Journal of Cellular Physiology 2009 220 1 119 128 2-s2.0-65549156409 10.1002/jcp.21742
50. Droz I., Mantel I., Ambresin A., Faouzi M., Schorderet D. F., Munier F. L., Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. British Journal of Ophthalmology 2008 92 4 513 517 2-s2.0-41849105420 10.1136/bjo.2007.127811 (Pubitemid 351497980)
51. Sepp T., Khan J. C., Thurlby D. A., Shahid H., Clayton D. G., Moore A. T., Bird A. C., Yates J. R. W., Bhattacharya S. S., Bishop P. N., Black P. D., Butt Z. A., Chong V. N. H., Day N. E., Edelsten C., Fitt A. W., Flanagan D. W., Glenn A. M., Harding S., Jakeman C. M., Jones C. D., Lamb R. J., Lotery A. J., Moffatt V., Moorman C. M., Peto T., Pushpanathan R. J., Redmond E., Rimmer T. J., Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Investigative Ophthalmology and Visual Science 2006 47 2 536 540 2-s2.0-33644872864 10.1167/iovs.05-1143 (Pubitemid 46768378)
52. Seddon J. M., George S., Rosner B., Rifai N., Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005 123 6 774 782 2-s2.0-20644467790 10.1001/archopht.123.6.774 (Pubitemid 41056598)
53. Gehrs K. M., Anderson D. H., Johnson L. V., Hageman G. S., Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Annals of Medicine 2006 38 7 450 471 2-s2.0-33751103471 10.1080/07853890600946724 (Pubitemid 44767496)
54. Hageman G. S., Hancox L. S., Taiber A. J., Gehrs K. M., Anderson D. H., Johnson L. V., Radeke M. J., Kavanagh D., Richards A., Atkinson J., Meri S., Bergeron J., Zernant J., Merriam J., Gold B., Allikmets R., Dean M., Hageman J., Hoballah J., Stockman H., Immonen I., Laine M., Jarva H., Järvelä I., Seitsonen S., Barile G., Chang S., Merriam J. C., Smith R. T., Yannuzzi L. A., Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Annals of Medicine 2006 38 8 592 604 2-s2.0-33847153137 10.1080/07853890601097030 (Pubitemid 46292019)
55. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M. J., Seddon J. M., Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nature Genetics 2006 38 9 1055 1059 2-s2.0-33748309136 10.1038/ng1873 (Pubitemid 44325932)
56. Nishiguchi K. M., Yasuma T. R., Tomida D., Nakamura M., Ishikawa K., Kikuchi M., Ohmi Y., Niwa T., Hamajima N., Furukawa K., Terasaki H., C9-R95X polymorphism in patients with neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science 2012 53 1 508 512 10.1167/iovs.11-8425
57. Maller J. B., Fagerness J. A., Reynolds R. C., Neale B. M., Daly M. J., Seddon J. M., Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nature Genetics 2007 39 10 1200 1201 2-s2.0-34748819371 10.1038/ng2131 (Pubitemid 47482689)
58. Heurich M., Martínez-Barricarte R., Francis N. J., Roberts D. L., Rodríguez De Córdoba S., Morgan B. P., Harris C. L., Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proceedings of the National Academy of Sciences of the United States of America 2011 108 21 8761 8766 2-s2.0-79957691055 10.1073/pnas.1019338108
59. Fagerness J. A., Maller J. B., Neale B. M., Reynolds R. C., Daly M. J., Seddon J. M., Variation near complement factor I is associated with risk of advanced AMD. European Journal of Human Genetics 2009 17 1 100 104 2-s2.0-57649215855 10.1038/ejhg.2008.140
60. Nozaki M., Raisler B. J., Sakurai E., Sarma J. V., Barnum S. R., Lambris J. D., Chen Y., Zhang K., Ambati B. K., Baffi J. Z., Ambati J., Drusen complement components C3a and C5a promote choroidal neovascularization. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2328 2333 2-s2.0-33144488589 10.1073/pnas.0408835103 (Pubitemid 43271669)
61. Rohrer B., Coughlin B., Kunchithapautham K., Long Q., Tomlinson S., Takahashi K., Holers V. M., The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization. Molecular Immunology 2011 48 6-7 e1 e8 2-s2.0-79951551543 10.1016/j.molimm.2010.12.016
62. Bora N. S., Kaliappan S., Jha P., Xu Q., Sohn J. H., Dhaulakhandi D. B., Kaplan H. J., Bora P. S., Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. The Journal of Immunology 2006 177 3 1872 1878 2-s2.0-33746190776 (Pubitemid 44092526)
63. Bora N. S., Kaliappan S., Jha P., Xu Q., Sivasankar B., Harris C. L., Morgan B. P., Bora P. S., CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. The Journal of Immunology 2007 178 3 1783 1790 2-s2.0-33846507393 (Pubitemid 46154650)
64. Bora N. S., Jha P., Lyzogubov V. V., Kaliappan S., Liu J., Tytarenko R. G., Fraser D. A., Morgan B. P., Bora P. S., Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice. The Journal of Biological Chemistry 2010 285 44 33826 33833
65. Cashman S. M., Ramo K., Kumar-Singh R., A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration. PLoS ONE 2011 6 4 2-s2.0-79955721853 10.1371/journal.pone. 0019078 e19078
66. Huang Y., Qiao F., Atkinson C., Holers V. M., Tomlinson S., A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. The Journal of Immunology 2008 181 11 8068 8076 2-s2.0-58149293645
67. Rohrer B., Long Q., Coughlin B., Brooks Wilson R., Huang Y., Qiao F., Tang P. H., Kunchithapautham K., Gilkeson G. S., Tomlinson S., A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Investigative Ophthalmology and Visual Science 2009 50 7 3056 3064 2-s2.0-67649989567 10.1167/iovs.08-2222
68. Bressler S. B., Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology 2009 116 10 S1 S7 2-s2.0-70349449737 10.1016/j.ophtha.2009.06.045
69. Gross O., Thomas C. J., Guarda G., Tschopp J., The inflammasome: an integrated view. Immunological Reviews 2011 243 1 136 151 10.1111/j.1600-065X. 2011.01046.x
70. Dowling J. K., O'Neill L. A., Biochemical regulation of the inflammasome. Critical Reviews in Biochemistry and Molecular Biology 2012 47 5 424 443 10.3109/10409238.2012.694844
71. Menu P., Vince J. E., The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clinical & Experimental Immunology 2011 166 1 1 15 10.1111/j.1365-2249.2011.04440.x
72. Mankan A. K., Kubarenko A., Hornung V., Immunology in clinic review series, focus on autoinflammatory diseases: inflammasomes: mechanisms of activation. Clinical & Experimental Immunology 2012 167 3 369 381 10.1111/j.1365-2249.2011.04534.x
73. Doyle S. L., Campbell M., Ozaki E., Salomon R. G., Mori A., Kenna P. F., Farrar G. J., Kiang A. S., Humphries M. M., Lavelle E. C., O'Neill L. A., Hollyfield J. G., Humphries P., NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nature Medicine 2012 18 5 791 798 10.1038/nm.2717
74. Tarallo V., Hirano Y., Gelfand B. D., DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012 149 4 847 859
75. Benoit M. E., Clarke E. V., Morgado P., Fraser D. A., Tenner A. J., Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. The Journal of Immunology 2012 188 11 5682 5693 10.4049/jimmunol.1103760
76. Tseng W. A., Thein T., Kinnunen K., Lashkari K., Gregory M. S., 'Amore P. A. D., Ksander B. R., NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Investigative Ophthalmology & Visual Science 2013 54 1 110 120 10.1167/iovs.12-10655
77. Nakahira K., Haspel J. A., Rathinam V. A., Lee S. J., Dolinay T., Lam H. C., Englert J. A., Rabinovitch M., Cernadas M., Kim H. P., Fitzgerald K. A., Ryter S. W., Choi A. M., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011 12 3 222 230
78. Shi C. S., Shenderov K., Huang N. N., Kabat J., Abu-Asab M., Fitzgerald K. A., Sher A., Kehrl J. H., Activation of autophagy by inflammatory signals limits IL-1 β production by targeting ubiquitinated inflammasomes for destruction. Nature Immunology 2012 13 3 255 263 10.1038/ni.2215
79. Kenney M. C., Chwa M., Atilano S. R., Pavlis J. M., Falatoonzadeh P., Ramirez C., Malik D., Hsu T., Woo G., Soe K., Nesburn A. B., Boyer D. S., Kuppermann B. D., Jazwinski S. M., Miceli M. V., Wallace D. C., Udar N., Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS ONE 2013 8 1 e54339
80. Patel N., Ohbayashi M., Nugent A. K., Ramchand K., Toda M., Chau K. Y., Bunce C., Webster A., Bird A. C., Ono S. J., Chong V., Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005 115 3 422 430 2-s2.0-21244450029 10.1111/j.1365-2567.2005.02173.x (Pubitemid 40896040)
81. Cherepanoff S., Mitchell P., Wang J. J., Gillies M. C., Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the blue mountains eye study. Clinical and Experimental Ophthalmology 2006 34 6 590 595 2-s2.0-33747347186 10.1111/j.1442-9071.2006. 01281.x
82. Morohoshi K., Goodwin A. M., Ohbayashi M., Ono S. J., Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. Journal of Autoimmunity 2009 33 3-4 247 254 2-s2.0-71649108317 10.1016/j.jaut.2009.09.003
83. Morohoshi K., Ohbayashi M., Patel N., Chong V., Bird A. C., Ono S. J., Identification of anti-retinal antibodies in patients with age-related macular degeneration. Experimental and Molecular Pathology 2012 93 2 193 199 10.1016/j.yexmp.2012.03.007
84. Morohoshi K., Patel N., Ohbayashi M., Chong V., Grossniklaus H. E., Bird A. C., Ono S. J., Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Experimental and Molecular Pathology 2012 92 1 64 73 10.1016/j.yexmp.2011.09.017
85. Dhillon B., Wright A. F., Tufail A., Pappworth I., Hayward C., Moore I., Strain L., Kavanagh D., Barlow P. N., Herbert A. P., Schmidt C. Q., Armbrecht A. M., Laude A., Deary I. J., Staniforth S. J., Holmes L. V., Goodship T. H. J., Marchbank K. J., Complement factor H autoantibodies and age-related macular degeneration. Investigative Ophthalmology and Visual Science 2010 51 11 5858 5863 2-s2.0-79953213653 10.1167/iovs.09-5124
86. Hollyfield J. G., Perez V. L., Salomon R. G., A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Molecular Neurobiology 2010 41 2-3 290 298 2-s2.0-77955085670 10.1007/s12035-010-8110-z
87. Liu B., Wei L., Meyerle C., Tuo J., Sen H. N., Li Z., Chakrabarty S., Agron E., Chan C. C., Klein M. L., Chew E., Ferris F., Nussenblatt R. B., Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. Journal of Translational Medicine 2011 9 111 2-s2.0-79960559299 10.1186/1479-5876-9-111
88. Wei L., Liu B., Tuo J., Shen D., Chen P., Li Z., Liu X., Ni J., Dagur P., Sen H. N., Jawad S., Ling D., Park S., Chakrabarty S., Meyerle C., Agron E., Ferris F. L. III, Chew E. Y., McCoy J. P., Blum E., Francis P. J., Klein M. L., Guymer R. H., Baird P. N., Chan C. C., Nussenblatt R. B., Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Reports 2012 2 5 1151 1158 10.1016/j.celrep.2012.10.013
89. Olsen T. W., Feng X., The minnesota grading system of eye bank eyes for age-related macular degeneration. Investigative Ophthalmology and Visual Science 2004 45 12 4484 4490 2-s2.0-9444225094 10.1167/iovs.04-0342 (Pubitemid 39564675)